News

Gustav Sten appointed CEO of IDL Diagnostics

May 19, 2026

IDL Diagnostics today announces that the Board of Directors has appointed Gustav Sten as the new Chief Executive Officer (CEO). Gustav Sten will assume the position on May 28, immediately following the Annual General Meeting, succeeding Anders Hultman. 

Gustav Sten most recently served as Chief Marketing Officer (CMO) at IDL Diagnostics and has been with the company for eight years. He brings extensive experience in sales, development, production, and quality control of diagnostic products. 

“We are very pleased to appoint Gustav Sten as our new CEO. During his years with the company, he has developed a deep understanding of our operations and has played a central role in driving our commercial development, most recently as Chief Marketing Officer. Gustav has also been a key contributor to our strategic initiatives, not least in developing our collaboration with concile. The Board is confident that he has the right expertise and drive to accelerate the company’s continued development, both within the rapid diagnostics segment and our focus on automated platforms,” says Max Pihlqvist, Chairman of the Board. 

Gustav Sten comments on his new role: 

“I am both excited and confident as I take on the role of CEO of IDL Diagnostics. Over the past five years, Anders has made a strong contribution in scaling the business and the organization. I now look forward to placing an even greater focus on commercialization and thereby driving further growth. We have a very exciting period ahead of us, both for our rapid tests and our products for automated platforms.”

Healthcare day 2026

On April 14, IDL participated at Redeye Healthcare Day. CEO Anders Hultman presented the company and shared more about its strategy, current and future markets, and our joint venture with concile. Watch the presentation here

read more

CACLP and meeting with new distributor

During CACLP in Xiamen, China’s largest IVD exhibition, IDL Diagnostics had the opportunity to meet a wide range of industry players, exchange valuable insights, and further explore the fast-evolving Chinese IVD market. The trip concluded in Tianjin with our first...

read more